Literature DB >> 15525561

Morphometric analysis of Th(1) and Th(2) cytokine expression in human pulmonary tuberculosis.

Xiyuan Bai1, Sarah E Wilson, Kathryn Chmura, Nicole E Feldman, Edward D Chan.   

Abstract

SETTING: Following infection with Mycobacterium tuberculosis, host cytokine responses influence disease manifestation. Differences in cytokine expression likely determine whether tuberculosis (TB) progresses, resolves, or becomes latent. In particular, the balance between Th(1) and Th(2) cytokine responses influences the expression of disease in individuals with pulmonary TB. OBJECTIVE AND
DESIGN: Since the cytokine microenvironment in pulmonary TB remains suboptimally defined, we utilized quantitative immunohistochemistry to compare the expression of Th(1) cytokines [interferon-gamma (IFNgamma) and interleukin-12 (IL-12)] and Th(2) cytokines [IL-4, IL-10, transforming growth factor-beta (TGFbeta)] in surgically resected lungs of seven TB patients and four control subjects. We also quantified IFNgamma-inducible protein 10 (IP-10) expression, a CXC chemokine for macrophages and T cells.
RESULTS: Morphometric analyses revealed increased IFNgamma, IL-12, IP-10, and TGFbeta in granulomas and in pneumonitis areas of TB lungs. In contrast, IL-10 and IL-4 expressions were globally reduced in TB lung tissues compared to controls.
CONCLUSION: Th(1) cytokines and TGFbeta are increased while Th(2) cytokines are decreased in well-formed pulmonary granulomas of TB patients compared to controls.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15525561     DOI: 10.1016/j.tube.2004.05.001

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  21 in total

1.  Cytokine expression profiles of bovine lymph nodes: effects of Mycobacterium bovis infection and bacille Calmette-Guérin vaccination.

Authors:  S Widdison; L J Schreuder; B Villarreal-Ramos; C J Howard; M Watson; T J Coffey
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  Diagnosis of gastrointestinal tuberculosis: Using cytomorphological, microbiological, immunological and molecular techniques - A study from Central India.

Authors:  Pradyumna Kumar Mishra; A Bhargava; R P Punde; N Pathak; P Desikan; A Jain; S Varshney; K K Maudar
Journal:  Indian J Clin Biochem       Date:  2010-05-27

3.  Cellular immune response in MDR-TB patients to different protein expression of MDR and susceptible Mycobacterium tuberculosis: Rv0147, a novel MDR-TB biomarker.

Authors:  Alireza Hadizadeh Tasbiti; Shamsi Yari; Seyed Davar Siadat; Payam Tabarsi; Kayvan Saeedfar; Fatemeh Yari
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

4.  IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease.

Authors:  Xiyuan Bai; Alida R Ovrutsky; Marinka Kartalija; Kathryn Chmura; Amanda Kamali; Jennifer R Honda; Rebecca E Oberley-Deegan; Charles A Dinarello; James D Crapo; Ling-Yi Chang; Edward D Chan
Journal:  Int Immunol       Date:  2011-10-27       Impact factor: 4.823

Review 5.  Latent tuberculosis infection: myths, models, and molecular mechanisms.

Authors:  Noton K Dutta; Petros C Karakousis
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

6.  Characterization of Th1- and Th2-type immune response in human multidrug-resistant tuberculosis.

Authors:  Q Tan; W P Xie; R Min; G Q Dai; C-C Xu; H Q Pan; C D Miao; Z Yang; W G Xu; H Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-25       Impact factor: 3.267

7.  Evaluation of T cell immune responses in multi-drug-resistant tuberculosis (MDR-TB) patients to Mycobacterium tuberculosis total lipid antigens.

Authors:  A S Shahemabadi; A Zavaran Hosseini; S Shaghsempour; M R Masjedi; M Rayani; M Pouramiri
Journal:  Clin Exp Immunol       Date:  2007-05-09       Impact factor: 4.330

8.  Characterization of human cellular immune responses to novel Mycobacterium tuberculosis antigens encoded by genomic regions absent in Mycobacterium bovis BCG.

Authors:  R Al-Attiyah; A S Mustafa
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

9.  Immunomodulation with recombinant interferon-gamma1b in pulmonary tuberculosis.

Authors:  Rod Dawson; Rany Condos; Doris Tse; Maryann L Huie; Stanley Ress; Chi-Hong Tseng; Clint Brauns; Michael Weiden; Yoshihiko Hoshino; Eric Bateman; William N Rom
Journal:  PLoS One       Date:  2009-09-15       Impact factor: 3.240

10.  Mycobacterium tuberculosis WhiB3 maintains redox homeostasis by regulating virulence lipid anabolism to modulate macrophage response.

Authors:  Amit Singh; David K Crossman; Deborah Mai; Loni Guidry; Martin I Voskuil; Matthew B Renfrow; Adrie J C Steyn
Journal:  PLoS Pathog       Date:  2009-08-14       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.